leadf
logo-loader
viewChemistree Technology Inc.

Chemistree says investee company ImmunoFlex won Health Canada approval for its Flex 10 antioxidant product

FLEX 10 is ImmunoFlex's unique N-Acetyl-L-cysteine formulation in packs of 30-600 mg capsules

Chemistree Technology Inc. - Chemistree Technology Inc (CSE:CHM) (OTCMKST:CHMJF) says investee company ImmunoFlex has received approval of Flex 10 from Health Canada
FLEX 10 is a powerful antioxidant, specifically packaged in aluminum blisters to reduce the potential for product oxidation

Chemistree Technology Inc (CSE:CHM) (OTCMKST:CHMJF) says investee company ImmunoFlex, a life sciences company developing clinically validated, pharmaceutical-grade natural health products based on advancements in genomics research, has received approval for its Flex 10 product from Health Canada.

"At ImmunoFlex, we work with the immune system to strengthen, support, and enhance our body's natural surveillance and response system," said ImmunoFlex CEO Chris Wagner in a statement.

READ: Chemistree to unveil virtual reality tour of Washington State cannabis facility at industry expo

"FLEX 10 is the first product in our line up of products designed to achieve this goal so we could not be more delighted with the Health Canada approval," Wagner noted. 

Chemistree President Karl Kottmeier added: "This is great news. We view the approval from Health Canada as a significant milestone for Immunoflex and look forward to announcing further advancements for this and their other products."

FLEX 10 is ImmunoFlex's unique N-Acetyl-L-cysteine formulation in packs of 30-600 mg capsules. FLEX 10 is a powerful antioxidant, specifically packaged in aluminum blisters to reduce the potential for product oxidation.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Chemistree Technology Inc.

Price: 0.085 CAD

CSE:CHM
Market: CSE
Market Cap: $3.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Chemistree Technology Inc. named herein, including the promotion by the Company of Chemistree Technology Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Buds & Duds: Cannabis stocks tumble led by mixed 3Q earnings from Aphria

Buds of Monday are Valens GroWorks Corp (CSE:VGW) (OTCMKTS:VGWCF), Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) while the duds are Aphria Inc (TSE:APHA) (NYSE:APHA), Cronos Group Inc (NASDAQ:CRON) (TSE:CRON). 

on 04/15/2019

2 min read